LYMPHOMAS
Clinical trials for LYMPHOMAS explained in plain language.
Never miss a new study
Get alerted when new LYMPHOMAS trials appear
Sign up with your email to follow new studies for LYMPHOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug shows promise for Hard-to-Treat cancers
Disease control CompletedThis early-phase study tested a new drug called FF-10502-01 in 106 adults with advanced solid tumors or lymphomas that had stopped responding to standard treatments. The goal was to find the safest dose and see if the drug could shrink tumors or slow disease progression. The stud…
Matched conditions: LYMPHOMAS
Phase: PHASE1, PHASE2 • Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. • Aim: Disease control
Last updated May 26, 2026 06:52 UTC
-
New drug combo tested for Tough-to-Treat cancers
Disease control CompletedThis early-phase study tested a combination of two cancer drugs, bortezomib and clofarabine, in 28 adults with advanced solid tumors, lymphomas, or myelodysplastic syndromes that had stopped responding to standard treatments. The main goal was to find a safe dose and see how well…
Matched conditions: LYMPHOMAS
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 20, 2026 11:53 UTC